Home » Headlines » Currently Reading:

Morning Headlines 11/11/24

November 10, 2024 Headlines No Comments

Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates

Clinician network and drug marketing operator Doximity reports Q2 results: revenue up 20%, adjusted EPS $0.30 versus $0.22, beating expectations for both and sending DOCS shares up 34% in valuing the company at $11 billion.

McKesson, Oracle competing for Veradigm

McKesson, Oracle, and private equity firm Thoma Bravo are reportedly competing to acquire health IT, data, and analytics company Veradigm in a deal expected to close by Thanksgiving.

Waystar Reports Third Quarter 2024 Results

Waystar reports Q3 results: revenue up 22%, adjusted EPS $0.14 versus –$0.09, beating expectations for both.

Leidos awarded Organ Procurement and Transplantation Network operations contract

HHS awards Leidos a $235 million contract to modernize the country’s Organ Procurement and Transplant Network (OPTN).



HIStalk Featured Sponsors

     

Text Ads


RECENT COMMENTS

  1. Wellness is a legitimate term but a wellness journey requires a long-term commitment from both patients and medical providers. Many…

  2. Regarding the chain Drugstore poll, would be interested in how many report actually using their pharmacy? I find the Rx…

  3. Re: Anthropic CEO human lifespan prediction Yeah, this isn't gonna happen. Not in the timeframe suggested, AI won't be involved,…

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

RSS Webinars

  • An error has occurred, which probably means the feed is down. Try again later.